ACOG — Alpha Cognition Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1655923 ·
Last close
$5.99
Market Cap
$130.43M
52W High
$7.55
52W Low
$4.87
ADV30
34,700
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 3,533,798 | 3,262,022 | -8,096,227 | -6,478,018 | 69,248,341 | 54,248,275 | 11,791,836 |
| Dec 2025 | 2,793,076 | 2,540,827 | -7,925,270 | -6,856,306 | 79,730,235 | 66,046,789 | 17,200,060 |
| Sep 2025 | 2,840,858 | 2,212,797 | -5,301,986 | -1,318,074 | 46,301,213 | 35,398,899 | 12,387,403 |
| Jun 2025 | 1,657,687 | 1,123,590 | -5,737,001 | -10,488,952 | 45,122,942 | 39,405,210 | 13,226,626 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,134,079
Investing CF
$-231,541
Financing CF
$39,050,066
CapEx
$-231,541
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.38
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-103,584,793
Inventory
$6,043,714
Receivables
$3,752,090
ST Investments
—
EBIT TTM
$-27,060,484
Pretax Income TTM
$-25,141,350
Interest Exp TTM
$50,857
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$10,825,419
EBITDA
$-27,270,894
Free Cash Flow
$-21,422,000
Enterprise Value
$76,178,672
Total Cash
$54,248,276
Total Debt
$0
Shares Out
21,774,104
Trailing EPS
$-1.39
Book Value
$2.64
ROE
-51.7%
ROA
-29.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,220,275 | -22,579,594 | -20,669,875 | 79,730,235 | 17,200,060 | — | -20,380,367 |
| Dec 2024 | 0 | -11,548,636 | -14,788,727 | 50,736,938 | 11,642,111 | — | -7,755,654 |
| Dec 2023 | 0 | -9,617,813 | -13,763,658 | 2,452,170 | 7,155,865 | — | -8,799,565 |
| Dec 2022 | 0 | -13,465,624 | -12,114,698 | 2,950,951 | 4,271,128 | — | -9,241,650 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.42
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VXRT | Vaxart, Inc. | $135.55M | $0.56 | — |
| AGEN | AGENUS INC | $137.42M | $3.30 | — |
| CRDL | Cardiol Therapeutics Inc. | $118.73M | $1.03 | — |
| OTLK | Outlook Therapeutics, Inc. | $147.45M | $1.22 | — |
| MOLN | MOLECULAR PARTNERS AG | $154.17M | $4.11 | — |
News headlines (Yahoo Finance, 1h cache)
We Think Alpha Cognition (NASDAQ:ACOG) Needs To Drive Business Growth Carefully
2026-06-13 13:52 · Yahoo
Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease
2026-06-09 12:00 · Yahoo
Genvor Appoints Donald Kalkofen as Chief Financial Officer
2026-05-21 12:00 · Yahoo
Alpha Cognition Inc. (NASDAQ:ACOG) Just Reported, And Analysts Assigned A US$16.00 Price Target
2026-05-17 13:29 · Yahoo
Alpha Cognition Inc. Common Stock Q1 2026 Earnings Call Summary
2026-05-15 12:30 · Yahoo
Alpha Cognition Q1 Earnings Call Highlights
2026-05-14 22:10 · Yahoo
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Tops Revenue Estimates
2026-05-14 21:50 · Yahoo
Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update
2026-05-14 20:15 · Yahoo
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
2026-05-07 14:00 · Yahoo
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026
2026-04-28 20:30 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-06-11 16:05:15 | 2026-06-09 | Opaleye Management Inc. | 10% | P - Purchase | 5.98 | 30728 | 183692 |